Top news of the week: 16.01.2023.
Leukemia
Drug
Form 10-K
Copyright
HIV Vaccine Trials Network
Medicine
Is the golden age of biotech stocks over? https://t.co/bMG4z2Haoq via @nathanvardi
Open
Is the golden age of biotech stocks over?
While good medicines will still be funded, biotech investing seems like it will be much harder this decade, and the overall impact of that on innovation remains to be seen.
Congrats @ramaiyar for hitting his $50,000 fundraising goal for Kilimanjaro Climb to Fight Cancer @fredhutch ! See you in Tanzania, Feb. 10. Team stands at $933,000. We're focused. Next stop: $1M. https://t.co/WH5NV4fusA
Open
Donate-to-Fight cancer with Me and Team Kilimanjaro
Take your mountain climbing experience to the next level. Join the CLIMB to Fight Breast Cancer and Climb one of the worlds tallest peaks to support an amazing charity!
Dr. Oz meets Moderna. #JPM23
I'll also note that BTIG is hosting a party tonight, so...?
https://t.co/6yxZnKl2R3 https://t.co/gVLNRBNWLF
Open
Califf addresses the Aduhelm files
He also noted that, thanks to new powers the FDA is being granted by Congress, in the future drugs will only be granted accelerated approval if a confirmatory trial is …
RT @ByMadeleineA: $ABBV deal with Anima today, aimed at "modulating mRNA biology with small molecules", follows earlier collabs with $LLY & $TAK https://t.co/c2KncYHvGN
OpenAbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and Immunology Targets
/PRNewswire/ -- AbbVie (NYSE: ABBV), and Anima Biotech (Anima), today announced a collaboration to discover and develop mRNA biology modulators for three...